Clinic
Beckley Oncology Associates INC
Beckley Oncology Associates INC was paid $5.01M by Medicaid between Jan 2018 and Dec 2023, across 63 billing codes. Its largest line is 96413, Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance — 17% of everything it billed.
33Billing provider infoBECKLEY ONCOLOGY ASSOCIATES INC
BECKLEY, WV 25801
BECKLEY, WV 25801
33aNPI1295747277assigned 08/11/2006
33bProvider typeRadiation Oncology Clinic/Center
28Total paid$5.01M
24GClaims131,906
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,888 | $2.97M | |
| 2019 | 11,967 | $472K | |
| 2020 | 18,579 | $403K | |
| 2021 | 22,838 | $294K | |
| 2022 | 28,474 | $435K | |
| 2023 | 27,160 | $429K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 17% | 5,721 | 3,700 | $876K |
| 77014 | 8.2% | 2,233 | 230 | $410K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 8.0% | 1,966 | 1,343 | $401K |
| 96375 | Therapeutic injection; each additional sequential IV push | 7.3% | 4,329 | 2,818 | $364K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.2% | 10,389 | 9,443 | $362K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 4.8% | 1,098 | 110 | $240K |
| J7050 | Infusion, normal saline solution, 250 cc | 4.5% | 1,163 | 864 | $227K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 4.5% | 1,817 | 1,248 | $227K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.6% | 5,590 | 2,133 | $180K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.0% | 2,888 | 2,652 | $151K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.8% | 26,303 | 19,401 | $141K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2.5% | 1,807 | 1,017 | $125K |
51 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 1,051 | $111K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 2.0% | 453 | $99K |
| 36415 | Collection of venous blood by venipuncture | 1.9% | 27,403 | $94K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 1.9% | 1,393 | $94K |
| 99223 | Prolong inpt eval add15 m | 1.8% | 860 | $90K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1.8% | 1,449 | $89K |
| 96415 | 1.8% | 486 | $88K | |
| 80053 | Comprehensive metabolic panel | 1.6% | 16,909 | $81K |
| 77427 | 1.6% | 630 | $79K | |
| 77336 | 1.5% | 470 | $76K | |
| 96417 | 1.5% | 550 | $73K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | 1.2% | 1,046 | $58K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.0% | 864 | $51K |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | <1% | 1,087 | $38K |
| 96367 | <1% | 495 | $33K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 308 | $24K |
| 99195 | <1% | 368 | $22K | |
| 82728 | <1% | 2,994 | $15K | |
| 77334 | <1% | 90 | $11K | |
| 99205 | Prolong outpt/office vis | <1% | 74 | $8K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 130 | $7K |
| 77300 | <1% | 46 | $7K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 262 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 518 | $6K |
| 85610 | <1% | 1,082 | $4K | |
| 77263 | <1% | 27 | $3K | |
| 83550 | <1% | 946 | $3K | |
| 77280 | <1% | 22 | $3K | |
| 83540 | <1% | 949 | $3K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 39 | $3K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 13 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 87 | $2K |
| J1453 | Injection, fosaprepitant, 1 mg | <1% | 169 | $2K |
| 96523 | <1% | 416 | $2K | |
| 82607 | <1% | 388 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 106 | $1K |
| 96411 | <1% | 52 | $1K | |
| 84439 | <1% | 280 | $1K | |
| 82746 | <1% | 337 | $1K | |
| 83615 | <1% | 594 | $977.10 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $555.09 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 26 | $429.18 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $400.78 |
| 82565 | <1% | 115 | $286.49 | |
| 82378 | <1% | 61 | $255.90 | |
| 84520 | <1% | 114 | $221.23 | |
| 96368 | <1% | 19 | $212.32 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 672 | $141.92 |
| 83735 | <1% | 39 | $138.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 73 | $54.83 |
| 99442 | <1% | 14 | $18.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLARSON, CARL (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Beckley Oncology Associates, INC. | Beckley, WV | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.